An Efficacy Predictive Method for Diabetic Ulcers Based on Higher-Order Markov Chain-Set Pair Analysis

Table 4

Index levels at each time point of 15 patients.

Index

t0

t1

t2

t3

t4

t0

t1

t2

t3

t4

t0

t1

t2

t3

t4

Patient a

Patient b

Patient c

K1

IV

III

II

II

II

IV

III

II

II

II

III

II

II

II

II

K2

IV

II

II

I

II

V

IV

III

II

II

IV

III

II

I

II

K3

III

II

I

I

I

IV

III

II

II

II

II

I

I

I

I

K4

III

I

I

I

I

II

I

I

I

I

IV

III

II

II

II

K5

II

II

I

I

I

III

II

II

I

II

II

I

I

I

I

K6

IV

III

II

I

II

IV

III

II

I

II

IV

III

II

II

II

K7

V

IV

III

II

II

V

III

II

II

II

V

IV

III

II

II

K8

III

I

I

I

I

III

II

I

I

I

III

II

II

I

I

K9

V

IV

III

II

II

III

II

I

II

II

IV

III

III

III

III

K10

V

IV

II

II

II

III

II

I

I

I

IV

III

III

II

II

Patient d

Patient e

Patient f

K1

IV

III

II

II

II

IV

III

II

II

II

III

II

II

II

II

K2

III

II

II

II

II

V

IV

III

II

II

V

IV

III

III

III

K3

II

I

I

I

I

IV

III

II

I

II

II

I

I

I

I

K4

II

II

I

I

I

II

I

I

I

I

IV

III

II

II

II

K5

III

II

I

I

I

III

II

I

I

II

II

I

I

I

I

K6

IV

III

II

I

II

IV

III

II

I

II

IV

III

II

II

II

K7

V

IV

III

II

II

IV

III

III

II

II

V

IV

III

II

III

K8

III

I

I

I

I

II

I

I

I

I

III

III

II

I

I

K9

V

III

II

II

II

IV

III

III

II

II

IV

III

II

I

II

K10

V

IV

IV

III

III

III

II

II

I

I

III

III

II

II

II

Patient g

Patient h

Patient i

K1

V

IV

III

III

III

IV

II

II

I

I

IV

III

II

I

II

K2

V

III

III

II

II

III

II

I

I

I

V

III

I

I

I

K3

IV

III

II

II

II

II

I

I

I

I

III

II

I

I

I

K4

II

II

I

I

I

III

II

I

I

I

II

I

II

I

I

K5

III

III

II

I

I

II

I

I

I

I

III

I

I

I

I

K6

IV

III

IV

III

III

V

IV

III

III

III

IV

III

III

II

II

K7

V

IV

IV

III

IV

IV

III

III

II

II

V

IV

IV

III

IV

K8

II

I

I

I

I

II

I

I

I

I

II

I

I

I

I

K9

IV

IV

III

II

III

IV

III

IV

III

III

IV

IV

III

II

III

K10

IV

III

II

I

II

V

IV

IV

III

IV

IV

III

II

II

II

Patient j

Patient k

Patient l

K1

IV

III

II

II

II

III

II

I

I

I

V

IV

III

III

III

K2

III

II

I

I

I

III

II

I

I

I

IV

III

II

I

II

K3

II

II

I

I

I

II

II

II

I

I

III

II

I

I

I

K4

III

I

I

I

I

II

I

I

I

I

III

I

I

I

I

K5

II

II

I

I

I

II

II

II

I

I

II

II

I

I

I

K6

IV

III

II

I

II

III

II

I

I

I

IV

III

II

II

II

K7

V

IV

III

II

III

IV

III

III

II

III

V

IV

III

II

II

K8

III

I

II

I

I

III

III

II

I

II

III

I

I

I

I

K9

V

IV

III

III

III

V

IV

III

II

III

V

III

IV

III

III

K10

V

IV

II

II

II

III

III

II

II

II

IV

IV

III

II

III

Patient m

Patient n

Patient o

K1

IV

III

II

II

II

III

II

II

I

I

III

III

II

II

II

K2

III

III

II

II

II

IV

III

IV

III

III

IV

IV

IV

III

III

K3

III

II

I

I

I

IV

IV

III

III

III

II

I

I

I

I

K4

IV

III

II

II

II

II

I

I

I

I

IV

III

II

II

I

K5

III

I

I

I

I

III

II

II

I

II

II

I

I

I

I

K6

V

IV

III

III

IV

IV

III

III

II

III

IV

III

II

I

II

K7

IV

III

IV

III

II

IV

III

II

II

II

V

IV

III

II

III

K8

V

III

II

II

II

III

II

I

I

I

III

II

II

I

II

K9

III

II

II

I

II

IV

III

III

II

II

IV

III

III

II

II

K10

III

III

II

I

II

III

II

II

I

I

III

III

II

I

I

The symptom index levels of patients a–o at five time points were obtained by evaluation after every treatment course in the study. Levels I, II, III, IV, and V were asymptomatic, lighter, moderate, heavier, and severe, respectively.